Apple (AAPL) is targetting dozens of OpenAI employees with legal letters, FT reports
Newsquawk Staff ·
- Apple is stepping-up aggressive tactics in trade secrets dispute with OpenAI
- US President Trump will deliver remarks in Florida on Friday, Georgia on Saturday and Michigan on Sunday, according to The Whiye House
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT
- Newsquawk Daily Asia-Pac Opening News - 23rd October 2026
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE
- US President Trump invokes Section 232 on wind turbine imports
Related headlines
- US President Trump on Iran, says may do it a little bit further5 hours ago
- US President Trump, on Ukraine’s Starlink (SPCX) access, says it’s a very interesting situation; won’t comment on whether he spoke to Elon Musk; bottom line is Musk put it back5 hours ago
- US President Trump signs EO on housing costs, aiming to cut mortgage insurance premiums6 hours ago
- US President Trump called Musk and asked him to lift Ukraine Starlink (SPCX) restrictions, WSJ reports7 hours ago
- US President Trump says "Iran is doing everything they can to drive up the price of Oil prior to the U.S. Midterm Election". 10 hours ago
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)5 hours ago
- PRE-MARKET CHINESE STOCKS NEWS: Earnings from China Telecom and Chow Tai fook30 min ago
- CRUDE WRAP: WTI (Z6) SETTLES USD 2.32 HIGHER AT 99.47/BBL; BRENT (Z6) SETTLES USD 4.35 HIGHER AT USD 113.17/BBL7 hours ago
- Ukraine President Zelensky says Ukraine is ready for peace talks at G20, but so far no such invitation8 hours ago
- An Israeli military official told Channel 12 that here is no reason to launch an attack on Iran before the elections; If we detect preparations in Iran for an attack, we will act8 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone7 hours ago
- PBoC sets USD/CNY midpoint at 6.7180 vs exp. 6.6758 (prev. 6.7195)34 min ago
- Money markets no longer full price a Fed rate hike before end of 20268 hours ago
- Newsquawk Daily US Earnings Estimates - 23rd October 2026: AXP9 hours ago
- Bloom Energy (BE) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.69), Revenue 1.24bln (exp. 1.06bln)5 hours ago